Khan, R.; Oskouian, B.; Lee, J.Y.; Hodgin, J.B.; Yang, Y.; Tassew, G.; Saba, J.D.
AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome. Int. J. Mol. Sci. 2023, 24, 15560.
https://doi.org/10.3390/ijms242115560
AMA Style
Khan R, Oskouian B, Lee JY, Hodgin JB, Yang Y, Tassew G, Saba JD.
AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome. International Journal of Molecular Sciences. 2023; 24(21):15560.
https://doi.org/10.3390/ijms242115560
Chicago/Turabian Style
Khan, Ranjha, Babak Oskouian, Joanna Y. Lee, Jeffrey B. Hodgin, Yingbao Yang, Gizachew Tassew, and Julie D. Saba.
2023. "AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome" International Journal of Molecular Sciences 24, no. 21: 15560.
https://doi.org/10.3390/ijms242115560
APA Style
Khan, R., Oskouian, B., Lee, J. Y., Hodgin, J. B., Yang, Y., Tassew, G., & Saba, J. D.
(2023). AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome. International Journal of Molecular Sciences, 24(21), 15560.
https://doi.org/10.3390/ijms242115560
